Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C18H25NO.BrH.H2O |
| Molecular Weight | 376.361 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O.Br.[2H]C([2H])([2H])OC1=CC=C2C[C@H]3[C@H]4CCCC[C@@]4(CCN3C([2H])([2H])[2H])C2=C1
InChI
InChIKey=STTADZBLEUMJRG-CDZAPMPLSA-N
InChI=1S/C18H25NO.BrH.H2O/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18;;/h6-7,12,15,17H,3-5,8-11H2,1-2H3;1H;1H2/t15-,17+,18+;;/m1../s1/i1D3,2D3;;
Dextromethorphan D6 is a weak uncompetitive antagonist of the NMDA receptor. Dextromethorphan is also acts at nicotinic receptors, sigma-1 rcptor and serotonin and norepinephrine transporters. The incorporation of deuterium serves to reduce dextromethorphan first-pass liver metabolism. AVP-786 is an oral formulation of a combination of deuterated (d6)-dextromethorphan and an ultra-low dose of quinidine. Avanir Pharmaceuticals launched a phase III development program of AVP-786 for the treatment of agitation in patients with Alzheimer's disease.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2569465
Created by
admin on Mon Mar 31 22:42:19 GMT 2025 , Edited by admin on Mon Mar 31 22:42:19 GMT 2025
|
PRIMARY | |||
|
C169891
Created by
admin on Mon Mar 31 22:42:19 GMT 2025 , Edited by admin on Mon Mar 31 22:42:19 GMT 2025
|
PRIMARY | |||
|
300000040301
Created by
admin on Mon Mar 31 22:42:19 GMT 2025 , Edited by admin on Mon Mar 31 22:42:19 GMT 2025
|
PRIMARY | |||
|
DE-128
Created by
admin on Mon Mar 31 22:42:19 GMT 2025 , Edited by admin on Mon Mar 31 22:42:19 GMT 2025
|
PRIMARY | |||
|
90479359
Created by
admin on Mon Mar 31 22:42:19 GMT 2025 , Edited by admin on Mon Mar 31 22:42:19 GMT 2025
|
PRIMARY | |||
|
1373497-18-7
Created by
admin on Mon Mar 31 22:42:19 GMT 2025 , Edited by admin on Mon Mar 31 22:42:19 GMT 2025
|
PRIMARY | |||
|
W9F1OD5N5J
Created by
admin on Mon Mar 31 22:42:19 GMT 2025 , Edited by admin on Mon Mar 31 22:42:19 GMT 2025
|
PRIMARY | |||
|
W9F1OD5N5J
Created by
admin on Mon Mar 31 22:42:19 GMT 2025 , Edited by admin on Mon Mar 31 22:42:19 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD